Response to R. L. Nevin “Considerations in the repurposing of mefloquine for prevention and treatment of osteoporosis”

Hannah M. Davis, Rafael Pacheco-Costa, Lilian Plotkin

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalBone
Volume114
DOIs
StatePublished - Sep 1 2018

Fingerprint

Mefloquine
Osteoporosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Histology

Cite this

Response to R. L. Nevin “Considerations in the repurposing of mefloquine for prevention and treatment of osteoporosis”. / Davis, Hannah M.; Pacheco-Costa, Rafael; Plotkin, Lilian.

In: Bone, Vol. 114, 01.09.2018.

Research output: Contribution to journalLetter

@article{68a7d8f5f747420f907983b51dae773e,
title = "Response to R. L. Nevin “Considerations in the repurposing of mefloquine for prevention and treatment of osteoporosis”",
author = "Davis, {Hannah M.} and Rafael Pacheco-Costa and Lilian Plotkin",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.bone.2018.07.005",
language = "English (US)",
volume = "114",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Response to R. L. Nevin “Considerations in the repurposing of mefloquine for prevention and treatment of osteoporosis”

AU - Davis, Hannah M.

AU - Pacheco-Costa, Rafael

AU - Plotkin, Lilian

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85050069742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050069742&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2018.07.005

DO - 10.1016/j.bone.2018.07.005

M3 - Letter

C2 - 30003962

AN - SCOPUS:85050069742

VL - 114

JO - Bone

JF - Bone

SN - 8756-3282

ER -